Report copyright - Q1 FY2020 (April 1 to June 30, 2020) Conference Call · 7/30/2020 · Q1 FY2020 Results 3 Results of Sumitovant: Revenue 3.7 SG&A expenses 6.4 R&D expenses 7.3 Core operating profit
Please pass captcha verification before submit form